New tool could better track facial muscle health in rare muscle disease

NCT ID NCT06425445

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new method to evaluate the strength and function of face and mouth muscles in people with facioscapulohumeral muscular dystrophy (FSHD). Twenty-two adults with a genetic diagnosis of FSHD took part. The goal was to see if this new assessment tool can reliably measure muscle performance, which may help doctors monitor the disease more closely in the future.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Mons

    Mons, Hainaut, 7000, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.